ProC Global, a new screening assay to assess the functionality of the protein C protein S anticoagulant pathway: Results of a multicenter trial in patients with thrombophilia

被引：0

作者：

Toulon, P

Wagner, C

机构：

[1] HOP COCHIN,HEMATOL LAB,PROC GLOBAL STUDY GRP,F-75674 PARIS,FRANCE

[2] BEHRING DIAGNOST,MARBURG,GERMANY

来源：

BLOOD | 1997年 / 90卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：664 / 664

页数：1

共 46 条

[31] Performance of a New Global Chromogenic Assay for Protein C Pathway (HemosIL ThromboPath) in the Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies
Toulon, Pierre A.
Martin-Toutain, Isabelle
Piette, Jean-Charles
Diemert, Marie-Claude
Ankri, Annick
BLOOD, 2008, 112 (11) : 795 - 795
[32] Anticoagulant response to Agkistrodon contortrix venom (ACV test): A new global test to screen for defects in the anticoagulant protein C pathway
Robert, A
Eschwege, V
Hameg, H
Drouet, L
Aillaud, MF
THROMBOSIS AND HAEMOSTASIS, 1996, 75 (04) : 562 - 566
[33] The result of the ProC Global assay is a risk factor for venous thromboembolism independent of its sensitivity for protein C pathway abnormalities. Results of a case-control study.
Toulon, PA
Perez, P
BLOOD, 2001, 98 (11) : 42A - 43A
[34] Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.
Toulon, Pierre A.
Martin-Toutain, Isabelle
Ankri, Annick
BLOOD, 2010, 116 (21) : 1564 - 1564
[35] A NOVEL THROMBOMODULIN BASED PLASMA ASSAY UNCOVERS ABNORMALITIES IN THE PROTEIN-S PROTEIN-C ANTICOAGULANT PATHWAY DISTINCT FROM RESISTANCE TO ACTIVATED PROTEIN-C IN MYOCARDIAL-INFARCTION PATIENTS
PRAUS, M
MO, XM
GROSSE, Y
BALDUS, B
MORSER, J
DECHEND, R
GULBA, DC
CIRCULATION, 1995, 92 (08) : 2989 - 2989
[36] A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study
Toulon, Pierre
Smirnov, Mikhail
Triscott, Mark
Safa, Omid
Biguzzi, Eugenia
Bouziane, Kader
Tripodi, Armando
THROMBOSIS RESEARCH, 2009, 124 (01) : 137 - 143
[37] A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results a multicenter study
Toulon, Pierre A.
Smirnov, Mikhail
Triscott, Mark
Tripodi, Armando
BLOOD, 2007, 110 (11) : 485A - 485A
[38] Performance of the HemosIL Thrombopath assay in the screening for protein C pathway abnormalities. preliminary results in 352 unselected patients with a history of thrombosis
Toulon, P. A.
Toutain, Martin, I
Ankri, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 738 - 738
[39] A PROTEIN-S FUNCTIONAL ASSAY YIELDS UNSATISFACTORY RESULTS IN PATIENTS WITH ACTIVATED PROTEIN-C RESISTANCE
SIMIONI, P
GAVASSO, S
LUNI, S
INVIDIATO, S
GIROLAMI, A
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (03) : 286 - 287
[40] Screening of Protein C Pathway Abnormalities in 597 Unselected Consecutive Patients with a History of Thrombosis Using a New Chromogenic Assay (HemosIL ThromboPath).
Toulon, Pierre A.
Martin-Toutain, Isabelle
Ankri, Annick
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E220 - E221

← 1 2 3 4 5 →